On the occasion of World Environment Day, it is important to highlight the close connection between environmental pollution ...
Analysis of health records revealed a reduced incidence of breast cancer among women using GLP-1 medications. The results do ...
GLP-1 medications are drugs that mimic a natural hormone in the body called glucagon-like peptide-1, which helps regulate ...
Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable ...
Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...
Ona Therapeutics Raises $86.6M to advance ADC cancer programmes and accelerate clinical development for resistant tumours.
A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic ...
Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from ...
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...
Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for its investigational candidate, ...
Other research linked the jab to a lower risk of death for breast cancer patients, and found they may have a protective ...
New research has found that persons living with breast, lung, bowel and liver cancers who take GLP-1 weight-loss drugs may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results